Evaluating the Relative Efficacy of Synthetic and Natural Drugs in Endometriosis Adopting Molecular Modelling Approach

Jump To References Section


  • School of Biotechnology, Banaras Hindu University, Varanasi – 221005, Uttar Pradesh ,IN
  • Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi – 221005, Uttar Pradesh ,IN
  • Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi – 221005, Uttar Pradesh ,IN
  • Department of Bioinformatics, Central University of South Bihar, Gaya – 824236, Bihar ,IN
  • Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi – 221005, Uttar Pradesh ,IN




Aromatase, Curcumin, Endometriosis, In-silico, Molecular Docking, Molecular Dynamics Simulation


Background: Endometriosis is a chronic inflammatory condition of high incidence and with serious consequences. Several synthetic compounds proved to be useful in treating its symptoms by inhibiting aromatase, which is responsible for the pathogenesis of this painful illness. Nevertheless, synthetic drugs inflict several side effects, including headaches, osteoporosis, and so on. This scenario advocates the search for therapeutic formulations based on natural compounds. Thus, the present study was hypothesized to evaluate the comparative efficacy of the synthetic and natural drugs used in endometriosis, using the bioinformatics approach. Methods: CB-Dock was employed to perform molecular docking of the aromatase enzyme with two synthetic and three natural drugs for predicting their molecular interactions, and binding affinities. The curcumin-aromatase complex was further subjected to MD simulations to determine its stability, and to apply it to natural compound-based computer-aided drug discovery. Results: Curcumin was observed to dock with a greater binding interaction with aromatase. The RMSD profile, hydrogen bonds, and the RMSF and Rg values of the complex were stabilised after 50 ns, which was an indicator of the stable binding pose of the curcumin-aromatase complex. Conclusion: These in-silico findings are the basis for proposing that curcumin can be considered as a potential binding agent to inhibit the aromatase enzyme in the treatment of endometriosis. Molecular modelling and dynamics results suggest that curcumin and aromatase form a stable complex and that curcumin can be targeted as a drug in the treatment of endometriosis


Download data is not yet available.


Metrics Loading ...




How to Cite

Singh, I., Shaw, R., Saha, P., Ojha, K. K., & Chaube, R. (2024). Evaluating the Relative Efficacy of Synthetic and Natural Drugs in Endometriosis Adopting Molecular Modelling Approach. Journal of Endocrinology and Reproduction, 27(4), 279–291. https://doi.org/10.18311/jer/2023/33854



Research Article



Mehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life. 2014; 7(3):349-57.

Giudice LC. Clinical practice: Endometriosis. N Engl J Med. 2010; 362(25):2389-98. https://doi.org/10.1056/ NEJMcp1000274 PMid:20573927 PMCid:PMC3108065

Olive DL. Endometriosis in clinical practice. London and New York: Taylor and Francis; 2005.

Fukunaga M. Uterus-like mass in the uterine cervix: Superficial cervical endometriosis with florid smooth muscle metaplasia? Virchows Arch. 2001; 438(3):302-5. https://doi.org/10.1007/s004280000299 PMid:11315628

Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009; 92(1):68-74. https://doi. org/10.1016/j.fertnstert.2008.04.056 PMid:18684448

Halme J, Hammond MG, Hulka JF, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynaecol. 1984; 64(2):151-4. https:// europepmc.org/article/med/6234483

Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927; 14(4):422-69. https:// doi.org/10.1016/S0002-9378(15)30003-X

Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS. A novelin vitromodel of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril. 2005; 84(1):16-21. https://doi.org/10.1016/j. fertnstert.2004.10.058 PMid:16009148

Wang Y, Nicholes K, Shih IM. The origin and pathogenesis of endometriosis. Annu. Rev Pathol. 2020; 15:71-95. https:// doi.org/10.1146/annurev-pathmechdis-012419-032654 PMid:31479615 PMCid:PMC7980953

Lagana AS, Garzon S, Götte M, Vigano P, Franchi M, Ghezzi F, et al. The pathogenesis of endometriosis: Molecular and cell biology insights. Int J Mol Sci. 2019; 20(22). https://doi.org/10.3390/ijms20225615 PMid:31717614 PMCid:PMC6888544

Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005; 20(10):2698-704. https://doi.org/10.1093/humrep/ dei135 PMid:15980014

Bulun SE. Endometriosis. N Engl J Med. 2009; 360(3):268-79. https://doi.org/10.1056/NEJMra0804690 PMid:19144942

Ashish A, Kusum K, Rai S, Chaube R, Mishra S, Singh R. Endometriosis diagnosis and management in adolescent patients and current treatment regimes. Cent Afr J Public Health. 2021; 1(2):10-13.

Sutton C, Adamson GD, Jones KD. Modern management of endometriosis. CRC Press; 2005. https://doi.org/10.1201/ b14621

Rafique S, Decherney AH. Medical management of endometriosis. Clin Obstet Gynecol. 2017; 60(3):485- 96. https://doi.org/10.1097/GRF.0000000000000292 PMid:28590310 PMCid:PMC5794019

Seal SL, Kamilya G, Mukherji J, De A, Ghosh D, Majhi AK. Aromatase inhibitors in recurrent ovarian endometriomas: Report of five cases with literature review. Fertil Steril. 2011; 95(1):291.e15-18. https://doi. org/10.1016/j.fertnstert.2010.05.021 PMid:20579642

Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril. 2006; 85(5):1307-18. https://doi.org/10.1016/j.fertnstert.2005.09.064 PMid:16647373

Ferrero S, Venturini PL, Gillott DJ, Remorgida V. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: A randomized controlled trial. Reprod Biol Endocrinol. 2011; 9:88. https://doi.org/10.1186/1477-7827-9-88 PMid:21693037 PMCid:PMC3141645

Rai KS, Chaube R. Endometriosis: Role of aromatase and recent advances in the disease treatment. J Obstet Gynaecol. 2019; 6(2):1137

Polyzos NP, Fatemi HM, Zavos A, Grimbizis G, Kyrou D, Velasco J-G, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011; 9(1):1-5. https://doi.org/10.1186/1477-7827-9-90 PMid:21693039 PMCid:PMC3142498

Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996; 81(1):174-9. https://doi.org/10.1210/jcem.81.1.8550748 PMid:8550748

Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012; 98(3):511-19. https:// doi.org/10.1016/j.fertnstert.2012.06.029 PMid:22819144 PMCid:PMC3836682

Bulun SE, Zeitoun KM, Takayama K, Sasano H. Molecular basis for treating endometriosis with aromatase inhibitors. Hum Reprod. 2000; 6(5):413-18. https://doi.org/10.1093/ humupd/6.5.413 PMid:11045871

Hashim HA. Potential role of aromatase inhibitors in the treatment of endometriosis. Int J Womens Health. 2014; 6:671-80. https://doi.org/10.2147/IJWH.S34684 PMid:25092998 PMCid:PMC4113402

Pavone ME, Bulun SE. Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation. J Clin Endocrinol Metab. 2013; 98(5):1838- 44. https://doi.org/10.1210/jc.2013-1328 PMid:23585659 PMCid:PMC3644592

Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012; 98(6):1370-79. https:// doi.org/10.1016/j.fertnstert.2012.08.053 PMid:22999792 PMCid:PMC3513666

Ferrero S, Venturini PL, Ragni N, Camerini G, Remorgida V. Pharmacological treatment of endometriosis: Experience with aromatase inhibitors. Drugs. 2009; 69(8):943-52. https://doi.org/10.2165/00003495-200969080-00001 PMid:19496625

Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE. Anastrazole and oral contraceptives: A novel treatment for endometriosis. Fertil Steril. 2005; 84(2). https:// doi.org/10.1016/j.fertnstert.2005.02.018 PMid:16084868

Speer LM, Mushkbar S, Erbele T. Chronic pelvic pain in women. Am Fam Physician. 2016; 93(5):380-7.

Selak V, Farquhar C, Prentice A, Singla AA. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2007; 4. https://doi.org/10.1002/14651858.CD000068. pub2

Arablou T, Mohammadi RK. Curcumin and endometriosis: Review on potential roles and molecular mechanisms. Biomed Pharmacother. 2018; 97: 91-7. https://doi. org/10.1016/j.biopha.2017.10.119 PMid:29080464

Vallee A, Lecarpentier Y. Curcumin and endometriosis. Int J Mol Sci. 2020; 21(7). https://doi.org/10.3390/ijms21072440 PMid:32244563 PMCid:PMC7177778

Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016; 3(3). https://doi.org/10.1002/14651858.CD002124.pub2

Bakhtshirin F, Abedi S, YusefiZoj P, Razmjooee D. The effect of aromatherapy massage with lavender oil on severity of primary dysmenorrhea in Arsanjan students. Iran J Nurs Midwifery Res. 2015; 20(1):156-60.

Venskutonis PR, Dapkevicius A, Baranauskiene M. Composition of the essential oil of lavender (Lavandula angustifolia Mill.) from Lithuania. J Essent Oil Res. 1997; 9(1):107-10. https://doi.org/10.1080/10412905.1997.9700727

Woronuk G, Demissie Z, Rheault M, Mahmoud S. Biosynthesis and therapeutic properties of lavandula essential oil constituents. Planta Med. 2011; 77(1):7-15. https://doi.org/10.1055/s-0030-1250136 PMid:20665367

Chowdhury D, Chhatar A, Nandan S, Swarupa S, Shaw R, Basu S, et al. Peptides on a rescue mission against the hazardous cidal chemicals used in Eastern Indian Agriculture: An in-silico approach based on field survey in 2020. Environ Health Eng Manag. 2021; 8(2):107-22. https://doi.org/10.34172/EHEM.2021.14

Liu Y,Grimm M, Dai W-t, Hou M-c, Xiao Z-X, Cao Y. CB-Dock: A web server for cavity detection-guided protein-ligand blind docking. Acta Pharmacol Sin. 2020; 41(1):138-44. https://doi.org/10.1038/s41401-019-0228-6 PMid:31263275 PMCid:PMC7471403

Rai KS, Singh K, Chaube R. Endometriosis: Pronouncing in reproductive women with role of estrogen, aromatase. Proc Zool Soc. 2019; 18(1):1-7

Remorgida V, Abbamonte LH, Ragni N, Fulcheri E, Ferrero S. Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust N Z J Obstet Gynaecol. 2007; 47(3):222-25. https://doi.org/10.1111/ j.1479-828X.2007.00722.x PMid:17550490

Pinzi L, Rastelli G. Molecular docking: Shifting paradigms in drug discovery. Int J Mol Sci. 2019; 20(18). https://doi.org/10.3390/ijms20184331 PMid:31487867 PMCid:PMC6769923

Zhang Y, Cao H, Yu Z, Peng H-Y, Zhang C-j. Curcumin inhibits endometriosis endometrial cells by reducing estradiol production. Iran J Reprod Med. 2013; 11(5):415-22. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3941414/

Swarnakar S, Paul S. Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. Indian J Biochem Biophys. 2009; 46(1):59-65. http://nopr. niscair.res.in/handle/123456789/3329

Soetikno V, Sari FR, Lakshmanan AP, Arumugam S, Harima M, Suzuki K, et al. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res. 2013; 57(9):1649- 59. https://doi.org/10.1002/mnfr.201200540 PMid:23174956

Arablou T, Mohammadi RK. Curcumin and endometriosis: Review on potential roles and molecular mechanisms. Biomed Pharmacother. 2018; 97:91-7. https://doi. org/10.1016/j.biopha.2017.10.119 PMid:29080464

Kizilay G, Uz YH, Seren G, Ulucam E, Yilmaz A, Cukur Z, et al. In vivo effects of curcumin and deferoxamine in experimental endometriosis. Adv Clin Exp Med. 2017; 26(2):207-13.